In humans, we had previously identified a non-mutated tumour epitope derived from the preprocalcitonin (ppCT) signal peptide (ppCT16–25) by a mechanism independent of proteasomes and TAP, involving signal peptidase (SP) and signal peptide peptidase (SPP)22. The gene discussed is HM13; the disease is neoplasm.